Microbiome Abundance Profiling: Precision microbiome profiling for insights into...
Microbiome Abundance Profiling: Precision microbiome profiling for insights into human health & research
The thousands of microbial species that compose the human gut microbiome are linked to diseases from cancer to diabetes, sparking tremendous interest among pharmaceutical/ medical researchers in microbiome analytics. Current analy...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
BiomeDxRx
Microbiome-based diagnostics and therapeutics
150K€
Cerrado
BugTheDrug
Predicting the effects of gut microbiota and diet on an indi...
2M€
Cerrado
PDC2021-121243-I00
PLATAFORMA DELFOS: SISTEMA DE INFORMACION PARA LA GESTION DE...
102K€
Cerrado
Duración del proyecto: 15 meses
Fecha Inicio: 2022-06-17
Fecha Fin: 2023-09-30
Líder del proyecto
PERSEUS BIOMICS
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
4M€
Descripción del proyecto
The thousands of microbial species that compose the human gut microbiome are linked to diseases from cancer to diabetes, sparking tremendous interest among pharmaceutical/ medical researchers in microbiome analytics. Current analytics methods are far too slow, expensive, and inaccurate to fulfil this need. Much faster techniques are essential for microbiome tracking over the course of disease states and therapies to discover correlations with disease and enable personalized medicine. Perseus MAP is the only microbiome analytics platform that will be able to handle this onslaught of demand, through a revolutionarily fast, high-throughput, and accurate technology based on DNA imaging techniques invented in the lab of our co-founders. We will massively accelerate microbiomics, starting with a central service lab, deploying satellite labs, and finally producing portable units for the microbiomics mass market, at a capacity of 300k profiles/yr analyzed in-house to seize a €2.5B market.